Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2001
DOI: 10.1016/s0735-1097(01)01683-7
|View full text |Cite
|
Sign up to set email alerts
|

ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
256
0
16

Year Published

2003
2003
2010
2010

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 1,267 publications
(275 citation statements)
references
References 42 publications
3
256
0
16
Order By: Relevance
“…Antihypertensive therapy should be administered to hypertensive patients with thoracic aortic diseases to achieve a goal of less than 140/90 mm Hg (patients without diabetes) or less than 130/80 mm Hg (patients with diabetes or chronic renal disease) to reduce the risk of stroke, myocardial infarction, heart failure, and cardiovascular death. [107][108][109][110][111] (Level of Evidence: B) 2. Beta adrenergic-blocking drugs should be administered to all patients with Marfan syndrome and aortic aneurysm to reduce the rate of aortic dilatation unless contraindicated.…”
Section: Recommendations For Blood Pressure Controlmentioning
confidence: 99%
“…Antihypertensive therapy should be administered to hypertensive patients with thoracic aortic diseases to achieve a goal of less than 140/90 mm Hg (patients without diabetes) or less than 130/80 mm Hg (patients with diabetes or chronic renal disease) to reduce the risk of stroke, myocardial infarction, heart failure, and cardiovascular death. [107][108][109][110][111] (Level of Evidence: B) 2. Beta adrenergic-blocking drugs should be administered to all patients with Marfan syndrome and aortic aneurysm to reduce the rate of aortic dilatation unless contraindicated.…”
Section: Recommendations For Blood Pressure Controlmentioning
confidence: 99%
“…To avoid and/or minimize life-threatening exacerbations and maintain quality of life, persons with heart failure must receive and make regular and appropriate use of recommended treatments and adopt life style changes. US Federal health guidelines suggest that clinicians counsel CHF patients to adhere to drug regimens and a very low sodium diet to avoid fluid retention (Hunt et al, 2002). They should also teach patients to regularly monitor early markers of fluid retention that herald a deterioration, including increases in weight, swelling and shortness of breath, and appropriately respond to these markers.…”
Section: Introductionmentioning
confidence: 99%
“…Many of the programs which have shown improvements in patient outcomes have required substantial investments in multi-disciplinary staff time which may prove to be unsustainable and infeasible in practices withlimited resources (Naylor, Brooten, & Jones, 1994;Rich, Beckham, & Wittenberg, 1995;Foranow et al, 1997;Hunt et al, 2002). Newer, less cumbersome programs involving nurse or pharmacist management have shown decreases in hospitalizations and improved quality of life (Blue et al, 2001;Krumholz et al, 2002;Varma, McElnay, Hughes, Passmore, & Varma, 1999;West et al, 1997), but withthe exception of one study (Stewart & Horowitz, 2002), there has been no clear improvement in survival.…”
Section: Introductionmentioning
confidence: 99%
“…[1,2] Acutely decompensated heart failure syndrome (AHFS) is a common emergency department (ED) presentation in patients with hemodialysis-dependent renal failure (HDRF). In the Acute Decompensated Heart Failure National Registry (ADHERE), 8.9% of the patients had HDRF, and another 26.9% had severe decreased glomerular filtration rate (15-29 mL/min/m 2 ).…”
Section: Background and Significancementioning
confidence: 99%